Fmoc-Val-Thr(Psi(Me,Me)pro)-OH

Fmoc-Val-Thr(Psi(Me,Me)pro)-OH is an Fmoc-protected dipeptide-like amino acid building block featuring an N-terminal fluorenylmethoxycarbonyl (Fmoc) group and a C-terminal carboxylic acid, with a valine residue linked to a threonine side chain bearing a Psi(Me,Me)pro substituent. The structure contains a defined stereochemical framework at the threonine α-center and a sterically constrained side-chain motif that can mimic peptide backbone geometry while maintaining side-chain functionality for controlled derivatization. The Psi(Me,Me)pro group introduces a protected/engineered side-chain environment that can influence hydrogen-bonding patterns and conformational preference during peptide assembly or downstream transformations. The presence of both Fmoc and a free carboxyl group supports standard protected amino acid synthesis workflows, including orthogonal deprotection and peptide coupling chemistries compatible with solid-phase or solution-phase peptide construction.

1. Peptide Synthesis

Fmoc-Val-Thr(Psi(Me,Me)pro)-OH is suitable for peptide building block preparation where Fmoc removal enables sequential N-to-C peptide coupling on automated synthesizers. The valine residue provides an aliphatic side chain that participates in hydrophobic packing, while the threonine α-amino acid center and the Psi(Me,Me)pro side-chain modification support incorporation of a constrained threonine analog into peptide chains. The C-terminal carboxylic acid functions as the coupling handle for formation of new amide bonds under standard peptide coupling conditions, supporting the construction of peptidomimetic sequences with controlled stereochemistry. Downstream, the resulting protected peptide intermediates can be further extended, cyclized, or functionalized depending on the target scaffold requirements in peptide science and synthetic methodology development.

2. Peptidomimetics And SAR

Fmoc-Val-Thr(Psi(Me,Me)pro)-OH can be employed in peptidomimetic construction for structure-activity relationship studies where side-chain conformational control is needed. The threonine-derived center and the Psi(Me,Me)pro substituent can modulate local backbone-like geometry and hydrogen-bonding capacity, enabling systematic comparison of analogs that vary steric bulk and side-chain orientation. Fmoc protection facilitates modular assembly of analog libraries, while the free carboxyl group supports incorporation at a defined position within longer sequences for SAR mapping. Generated peptide analogs can then be used as biochemical research intermediates for binding studies, target engagement assays, and mechanistic investigations that rely on stereochemically consistent amino acid replacements.

3. Chemical Biology Labeling

Fmoc-Val-Thr(Psi(Me,Me)pro)-OH is applicable to chemical biology workflows that require site-defined peptide fragments for labeling and molecular recognition studies. The Fmoc group supports controlled assembly of a peptide segment with a defined N-terminus, while the threonine-based stereocenter and Psi(Me,Me)pro side-chain motif can be selected to tune reactivity and interaction profiles during conjugation. The C-terminal carboxylic acid enables conversion into activated derivatives for subsequent conjugation strategies, supporting preparation of labeled peptides, affinity probes, or internal standards. Downstream use includes generating well-defined biomolecule-modifying reagents and analytical reference materials that retain stereochemical integrity from amino acid building block through final conjugate.

4. Process Chemistry Intermediate

Fmoc-Val-Thr(Psi(Me,Me)pro)-OH can serve as a controlled intermediate in process chemistry for manufacturing peptide fragments and protected amino acid derivatives at scale. The orthogonal protection pattern, with Fmoc on nitrogen and a carboxylic acid at the C-terminus, supports predictable deprotection and coupling logic in manufacturing routes that rely on stepwise protection management. The presence of the Psi(Me,Me)pro side-chain substituent provides a stable, engineered functionality that can be carried through peptide assembly without uncontrolled side reactions, improving reproducibility of downstream transformations. The compound's defined stereochemistry and protected-group architecture make it suitable for fine chemical synthesis planning where consistent intermediate quality and coupling compatibility are required for reliable batch-to-batch peptide production.

5. Unnatural Amino Acid Incorporation

Fmoc-Val-Thr(Psi(Me,Me)pro)-OH is suitable for unnatural amino acid incorporation into peptide frameworks to probe backbone mimicry and side-chain constrained behavior. The Psi(Me,Me)pro-modified threonine element functions as a stereochemically defined analog that can replace native residues while preserving the overall connectivity required for amide bond formation. Fmoc protection enables compatibility with standard peptide coupling cycles, while the free carboxyl group allows placement at specific positions within a peptide sequence for controlled fragment assembly. Downstream, incorporation into longer constructs supports generation of stereochemically consistent peptidomimetics and enzyme-interaction probes used in biochemical research and synthetic methodology development.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. Myotropic activity of allatostatins in tenebrionid beetles

3. TMEM16F and dynamins control expansive plasma membrane reservoirs

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes